» Articles » PMID: 16569852

Antitrypanosomal and Antileishmanial Activities of Flavonoids and Their Analogues: in Vitro, in Vivo, Structure-activity Relationship, and Quantitative Structure-activity Relationship Studies

Overview
Specialty Pharmacology
Date 2006 Mar 30
PMID 16569852
Citations 125
Authors
Affiliations
Soon will be listed here.
Abstract

Trypanosomiasis and leishmaniasis are important parasitic diseases affecting millions of people in Africa, Asia, and South America. In a previous study, we identified several flavonoid glycosides as antiprotozoal principles from a Turkish plant. Here we surveyed a large set of flavonoid aglycones and glycosides, as well as a panel of other related compounds of phenolic and phenylpropanoid nature, for their in vitro activities against Trypanosoma brucei rhodesiense, Trypanosoma cruzi, and Leishmania donovani. The cytotoxicities of more than 100 compounds for mammalian L6 cells were also assessed and compared to their antiparasitic activities. Several compounds were investigated in vivo for their antileishmanial and antitrypanosomal efficacies in mouse models. Overall, the best in vitro trypanocidal activity for T. brucei rhodesiense was exerted by 7,8-dihydroxyflavone (50% inhibitory concentration [IC50], 68 ng/ml), followed by 3-hydroxyflavone, rhamnetin, and 7,8,3',4'-tetrahydroxyflavone (IC50s, 0.5 microg/ml) and catechol (IC50, 0.8 microg/ml). The activity against T. cruzi was moderate, and only chrysin dimethylether and 3-hydroxydaidzein had IC50s less than 5.0 microg/ml. The majority of the metabolites tested possessed remarkable leishmanicidal potential. Fisetin, 3-hydroxyflavone, luteolin, and quercetin were the most potent, giving IC50s of 0.6, 0.7, 0.8, and 1.0 microg/ml, respectively. 7,8-Dihydroxyflavone and quercetin appeared to ameliorate parasitic infections in mouse models. Generally, the test compounds lacked cytotoxicity in vitro and in vivo. By screening a large number of flavonoids and analogues, we were able to establish some general trends with respect to the structure-activity relationship, but it was not possible to draw clear and detailed quantitative structure-activity relationships for any of the bioactivities by two different approaches. However, our results can help in directing the rational design of 7,8-dihydroxyflavone and quercetin derivatives as potent and effective antiprotozoal agents.

Citing Articles

Combination Therapy and Phytochemical-Loaded Nanosytems for the Treatment of Neglected Tropical Diseases.

Soto-Sanchez J, Garza-Trevino G Pharmaceutics. 2024; 16(10).

PMID: 39458571 PMC: 11510106. DOI: 10.3390/pharmaceutics16101239.


Methanolic Extract of (Rhizophoraceae) Leaves: Phytochemical Characterization and Anthelmintic Evaluation against .

Franca W, Filho S, Cavalcante L, Gomes M, Goncalves M, Diniz E Pharmaceuticals (Basel). 2024; 17(9).

PMID: 39338340 PMC: 11435278. DOI: 10.3390/ph17091178.


Pilot-Scale Screening of Clinically Approved Drugs to Identify Uridine Insertion/Deletion RNA Editing Inhibitors in .

Rostamighadi M, Kamelshahroudi A, Pitsitikas V, Jacobson K, Salavati R ACS Infect Dis. 2024; 10(9):3289-3303.

PMID: 39118542 PMC: 11456206. DOI: 10.1021/acsinfecdis.4c00394.


Efficacy of a Combined Herbal Product Containing and in Zoonotic Cutaneous Leishmaniasis Patients Treated along Glucantime ®.

Bozorgzade S, Kalantar-Khandani S, Amiri R, Dehesh T, Karegar-Borzi H Iran J Parasitol. 2024; 19(2):203-213.

PMID: 39011534 PMC: 11246213. DOI: 10.18502/ijpa.v19i2.15856.


In vitro antileishmanial activities of hydro-methanolic crude extracts and solvent fractions of Clematis simensis fresen leaf, and Euphorbia abyssinica latex.

Worku K, Araya D, Tesfa H, Birru E, Hailu A, Aemero M Medicine (Baltimore). 2024; 103(18):e38039.

PMID: 38701291 PMC: 11062719. DOI: 10.1097/MD.0000000000038039.


References
1.
Kayser O . Nanosuspensions for the formulation of aphidicolin to improve drug targeting effects against leishmania infected macrophages. Int J Pharm. 2000; 196(2):253-6. DOI: 10.1016/s0378-5173(99)00434-2. View

2.
Koide T, Nose M, Inoue M, Ogihara Y, Yabu Y, Ohta N . Trypanocidal effects of gallic acid and related compounds. Planta Med. 1998; 64(1):27-30. DOI: 10.1055/s-2006-957360. View

3.
HARBORNE J, Williams C . Advances in flavonoid research since 1992. Phytochemistry. 2000; 55(6):481-504. DOI: 10.1016/s0031-9422(00)00235-1. View

4.
Dias J, Silveira A, Schofield C . The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz. 2002; 97(5):603-12. DOI: 10.1590/s0074-02762002000500002. View

5.
del Rayo Camacho M, Phillipson J, Croft S, Marley D, Kirby G, Warhurst D . Assessment of the antiprotozoal activity of Galphimia glauca and the isolation of new nor-secofriedelanes and nor-friedelanes. J Nat Prod. 2002; 65(10):1457-61. DOI: 10.1021/np010419i. View